Payment overview · 2025
General Payments
$18.63
1 reported records · 1 companies
Healthcare provider profile · identity verified
Haresh J Patel, M.D.
Allopathic & Osteopathic Physicians|Internal Medicine · GRUNDY, VA · NPI 1245209402
Verified facts
What the public records show
CMS Open Payments records show Haresh J Patel, M.D. received $18.63 in general payments during 2025 across 1 reported records.
Shockwave Medical, Inc accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Shockwave Medical, Inc | Unresolved — no canonical attribution shown | $18.63 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $18.63 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter Normalized: shockwave ivl system with the shockwave c2 coronary ivl catheter |
Device | Shockwave Medical, Inc | $18.63 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
None of this doctor’s payer companies has same-entity product evidence that passes the publication threshold. The site does not infer company ownership, affiliates, or generic manufacturers.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Gabapentin | Gabapentin | 577 | 84 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 413 | 42 |
| Levothyroxine Sodium | Levothyroxine Sodium | 396 | 55 |
| Atorvastatin Calcium | Atorvastatin Calcium | 346 | 59 |
| Pantoprazole Sodium | Pantoprazole Sodium | 341 | 50 |
| Lisinopril | Lisinopril | 290 | 44 |
| Omeprazole | Omeprazole | 289 | 49 |
| Potassium Chloride | Potassium Chloride | 280 | 47 |
| Metoprolol Tartrate | Metoprolol Tartrate | 260 | 40 |
| Amlodipine Besylate | Amlodipine Besylate | 236 | 44 |
| Ibuprofen | Ibuprofen | 195 | 29 |
| Hydrochlorothiazide | Hydrochlorothiazide | 192 | 29 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 189 | 29 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 186 | 37 |
| Fluticasone Propionate | Fluticasone Propionate | 177 | 33 |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 172 | 32 |
| Meloxicam | Meloxicam | 172 | 35 |
| Montelukast Sodium | Montelukast Sodium | 169 | 26 |
| Famotidine | Famotidine | 160 | 26 |
| Furosemide | Furosemide | 147 | 30 |
| Metformin Hcl | Metformin Hcl | 147 | 22 |
| Tizanidine Hcl | Tizanidine Hcl | 143 | 26 |
| Alprazolam | Alprazolam | 142 | 19 |
| Simvastatin | Simvastatin | 131 | 18 |
| Pravastatin Sodium | Pravastatin Sodium | 128 | 24 |
| Metoprolol Succinate | Metoprolol Succinate | 119 | 25 |
| Allopurinol | Allopurinol | 115 | 13 |
| Sucralfate | Sucralfate | 115 | 16 |
| Tamsulosin Hcl | Tamsulosin Hcl | 113 | 18 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 111 | 14 |
| Clopidogrel | Clopidogrel Bisulfate | 110 | 17 |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 105 | 15 |
| Glimepiride | Glimepiride | 99 | 18 |
| Ondansetron Hcl | Ondansetron Hcl | 97 | 18 |
| Losartan Potassium | Losartan Potassium | 95 | 23 |
| Dutasteride | Dutasteride | 87 | 15 |
| Diclofenac Sodium | Diclofenac Sodium | 80 | 18 |
| Eliquis | Apixaban | 80 | 11 |
| Mirtazapine | Mirtazapine | 78 | 12 |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 71 | 15 |
| Jardiance | Empagliflozin | 70 | 11 |
| Ozempic | Semaglutide | 70 | 11 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 63 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 62 | 11 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 60 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 57 | 41 |
| Levofloxacin | Levofloxacin | 54 | 39 |
| Symbicort | Budesonide/Formoterol Fumarate | 52 | 12 |
| Ezetimibe | Ezetimibe | 51 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 51 | 13 |
| Carvedilol | Carvedilol | 50 | suppressed |
| Naproxen | Naproxen | 47 | 13 |
| Azithromycin | Azithromycin | 46 | 39 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 46 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 46 | suppressed |
| Atenolol | Atenolol | 45 | suppressed |
| Dexamethasone | Dexamethasone | 44 | 28 |
| Duloxetine Hcl | Duloxetine Hcl | 43 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 43 | 11 |
| Ventolin Hfa | Albuterol Sulfate | 43 | suppressed |
| Amoxicillin | Amoxicillin | 42 | 29 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 42 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 41 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 41 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 39 | suppressed |
| Lorazepam | Lorazepam | 37 | suppressed |
| Nystatin | Nystatin | 37 | suppressed |
| Promethazine Hcl | Promethazine Hcl | 37 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 37 | 30 |
| Citalopram Hbr | Citalopram Hydrobromide | 36 | suppressed |
| Clonazepam | Clonazepam | 36 | suppressed |
| Baclofen | Baclofen | 35 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 35 | suppressed |
| Temazepam | Temazepam | 35 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 34 | suppressed |
| Nabumetone | Nabumetone | 34 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 33 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 30 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 30 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 30 | suppressed |
| Trazodone Hcl | Trazodone Hcl | 30 | suppressed |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 29 | suppressed |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 28 | suppressed |
| Januvia | Sitagliptin Phosphate | 28 | suppressed |
| Spironolactone | Spironolactone | 28 | suppressed |
| Lansoprazole | Lansoprazole | 27 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 26 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 26 | suppressed |
| Fluconazole | Fluconazole | 26 | 11 |
| Insulin Lispro Protamine Mix | Insulin Lispro Protamin/Lispro | 25 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 24 | suppressed |
| Trulicity | Dulaglutide | 24 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 23 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 23 | suppressed |
| Methimazole | Methimazole | 22 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 21 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 21 | suppressed |
| Nitroglycerin | Nitroglycerin | 21 | suppressed |
| Sertraline Hcl | Sertraline Hcl | 21 | suppressed |
| Tymlos | Abaloparatide | 21 | suppressed |
| Celecoxib | Celecoxib | 20 | suppressed |
| Ketoconazole | Ketoconazole | 20 | suppressed |
| Ondansetron Odt | Ondansetron | 20 | 11 |
| Rizatriptan | Rizatriptan Benzoate | 20 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 19 | suppressed |
| Lactulose | Lactulose | 19 | suppressed |
| Alcohol Pads | Alcohol Antiseptic Pads | 18 | suppressed |
| Easy Comfort Pen Needles | Pen Needle, Diabetic | 18 | suppressed |
| Entresto | Sacubitril/Valsartan | 18 | suppressed |
| Nateglinide | Nateglinide | 18 | suppressed |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 17 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 17 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 17 | 11 |
| Breyna | Budesonide/Formoterol Fumarate | 16 | suppressed |
| Mometasone Furoate | Mometasone Furoate | 16 | suppressed |
| Mupirocin | Mupirocin | 16 | suppressed |
| Colchicine | Colchicine | 15 | suppressed |
| Divalproex Sodium | Divalproex Sodium | 15 | suppressed |
| Linzess | Linaclotide | 15 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 14 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 14 | suppressed |
| Humalog Mix 75-25 Kwikpen | Insulin Lispro Protamin/Lispro | 14 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 14 | suppressed |
| Megestrol Acetate | Megestrol Acetate | 14 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 14 | suppressed |
| Pro Comfort Alcohol Pads | Alcohol Antiseptic Pads | 14 | suppressed |
| Colestipol Hcl | Colestipol Hcl | 13 | suppressed |
| Escitalopram Oxalate | Escitalopram Oxalate | 13 | suppressed |
| Naproxen Sodium | Naproxen Sodium | 13 | suppressed |
| Pregabalin | Pregabalin | 13 | suppressed |
| Calcitriol | Calcitriol | 12 | suppressed |
| Dexlansoprazole Dr | Dexlansoprazole | 12 | suppressed |
| Metolazone | Metolazone | 12 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 12 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 12 | suppressed |
| Penicillin V Potassium | Penicillin V Potassium | 12 | suppressed |
| Potassium Citrate Er | Potassium Citrate | 12 | suppressed |
| Ranolazine Er | Ranolazine | 12 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 12 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 12 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 11 | suppressed |
| Novolog Mix 70-30 | Insulin Aspart Prot/Insuln Asp | 11 | suppressed |
| Prednisone | Prednisone | 11 | suppressed |
| Sulindac | Sulindac | 11 | suppressed |
| Synthroid | Levothyroxine Sodium | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $18.63 · 1 records | Shockwave Medical, Inc | Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error